Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Glycogen Metabolism Disease Treatment Market by Type (OTC, Rx Drugs), By Application (Hospital, Retail Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Glycogen Metabolism Disease Treatment Market by Type (OTC, Rx Drugs), By Application (Hospital, Retail Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 326091 4200 Medical Care 377 202 Pages 4.9 (40)
                                          

Market Overview:


The global glycogen metabolism disease treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of glycogen storage diseases, rising awareness about these diseases, and technological advancements in the field of glycogen metabolism disease treatment. The global glycogen metabolism disease treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into OTC drugs and Rx drugs. The OTC drugs segment is expected to grow at a higher CAGR than that of Rx drugs during the forecast period owing to their easy availability and lower cost as compared to Rx drugs. On the basis of application,the hospital segment dominatesthe globalglycogen metabolismdisease treatmentmarket duetoits high demand for various treatments for different typesofglycogens storage diseasesand growing number oftreatment centers worldwide.


Global Glycogen Metabolism Disease Treatment Industry Outlook


Product Definition:


Glycogen metabolism disease treatment is a medical term that refers to the various treatments available for diseases that affect how the body processes glycogen. Glycogen is a type of carbohydrate that is stored in the liver and muscles. It is used as energy for physical activity. Diseases that affect glycogen metabolism can cause problems with physical activity, weight gain, and other health issues. There are several different treatments available for these diseases, including medications, dietary changes, and surgery. The importance of glycogen metabolism disease treatment depends on the specific disease and its effects on the individual's life.


OTC:


OTC stands for Over-the-Counter and is a generic name for drugs sold in the form of tablets, capsules or liquids without a prescription. OTC drug products are intended to be used at home without the help of a healthcare professional. Most OTC drugs are used as substitutes for prescription medicines; however, some can be used as standalone medications.


The global OTC market was valued at USD 62 billion in 2016.


Rx Drugs:


Rx drugs and it's usage in glycogen metabolism disease treatment market is expected to grow at a lucrative rate during the forecast period. The key drivers of this market are increasing prevalence of diabetes due to aging, obesity, and an unhealthy lifestyle along with growing demand for effective medications that can manage or cure diseases. According to the International Diabetes Federation (IDF), 463 million people were suffering from diabetes globally in 2014 which is expected to reach 700 million by 2035.


Application Insights:


The retail pharmacy segment held the largest market share of over 70% in 2017. The growing demand for OTC and self-medication is one of the key factors driving this segment. According to a study published in NCBI, around 40% of patients with diabetes self-manage their disease without consulting healthcare professionals due to easy access to information regarding glycemic control at home using online resources such as Google search and YouTube videos. This trend is expected to drive the treatment of glycogen metabolism diseases through retail pharmacies over the forecast period.


The hospital application segment accounted for a significant revenue share in 2017 owing to increasing prevalence rates coupled with rising awareness about treatment options available for these disorders outside medical settings, especially in developing regions like Asia Pacific and Latin America where internet penetration rate is still low compared to other regions like North America and Europe.


Regional Analysis:


North America accounted for the largest share of the global market in 2017 owing to favorable healthcare resources, high adoption of advanced therapeutics, and a large number of patients suffering from gastrointestinal disorders. Glycogen storage disease is relatively rare in North America as compared to Europe and Asia Pacific. However, increasing awareness among people about these diseases has increased the demand for treatment options over this region.


Asia Pacific is expected to be one of the fastest-growing regions during the forecast period due to rising disposable income levels coupled with growing health awareness among individuals especially children & adolescents resulting into an increase in prescriptions drugs usage rates over this region.


Growth Factors:


  • Increasing prevalence of glycogen metabolism diseases
  • Growing awareness about the benefits of glycogen metabolism disease treatment
  • Technological advancements in glycogen metabolism disease treatment procedures
  • Rising demand for personalized medicine in glycogen metabolism disease treatment
  • increasing number of clinical trials for new therapies

Scope Of The Report

Report Attributes

Report Details

Report Title

Glycogen Metabolism Disease Treatment Market Research Report

By Type

OTC, Rx Drugs

By Application

Hospital, Retail Pharmacy

By Companies

Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

202

Number of Tables & Figures

142

Customization Available

Yes, the report can be customized as per your need.


Global Glycogen Metabolism Disease Treatment Market Report Segments:

The global Glycogen Metabolism Disease Treatment market is segmented on the basis of:

Types

OTC, Rx Drugs

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Retail Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck
  2. Novartis
  3. Takeda Pharmaceutical
  4. Astra Zeneca
  5. Boehringer Ingelheim
  6. KOWA
  7. Kythera
  8. Fuji yakuhin
  9. LG Life Science
  10. Metsubishi Tanabe Pharma

Global Glycogen Metabolism Disease Treatment Market Overview


Highlights of The Glycogen Metabolism Disease Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. OTC
    2. Rx Drugs
  1. By Application:

    1. Hospital
    2. Retail Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Glycogen Metabolism Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Glycogen Metabolism Disease Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Glycogen metabolism disease treatment is a combination of dietary and pharmaceutical interventions. Dietary interventions may include reducing the amount of glycogen in the diet, or increasing the amount of protein in the diet. Pharmaceutical interventions may include medications that help to break down glycogen, or medications that block enzymes involved in glycogen metabolism.

Some of the major players in the glycogen metabolism disease treatment market are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma.

The glycogen metabolism disease treatment market is expected to register a CAGR of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glycogen Metabolism Disease Treatment Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Glycogen Metabolism Disease Treatment Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Glycogen Metabolism Disease Treatment Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Glycogen Metabolism Disease Treatment Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Glycogen Metabolism Disease Treatment Market Size & Forecast, 2020-2028       4.5.1 Glycogen Metabolism Disease Treatment Market Size and Y-o-Y Growth       4.5.2 Glycogen Metabolism Disease Treatment Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 OTC
      5.2.2 Rx Drugs
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Retail Pharmacy
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Glycogen Metabolism Disease Treatment Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Glycogen Metabolism Disease Treatment Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 OTC
      9.6.2 Rx Drugs
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Retail Pharmacy
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 OTC
      10.6.2 Rx Drugs
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Retail Pharmacy
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 OTC
      11.6.2 Rx Drugs
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Retail Pharmacy
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 OTC
      12.6.2 Rx Drugs
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Retail Pharmacy
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 OTC
      13.6.2 Rx Drugs
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Retail Pharmacy
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Glycogen Metabolism Disease Treatment Market: Competitive Dashboard
   14.2 Global Glycogen Metabolism Disease Treatment Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Merck
      14.3.2 Novartis
      14.3.3 Takeda Pharmaceutical
      14.3.4 Astra Zeneca
      14.3.5 Boehringer Ingelheim
      14.3.6 KOWA
      14.3.7 Kythera
      14.3.8 Fuji yakuhin
      14.3.9 LG Life Science
      14.3.10 Metsubishi Tanabe Pharma

Our Trusted Clients

Contact Us